However, further studies indicated that DUXAP10 exerted oncogenic functions in human NSCLC cells by interacting with LSD1 and repressing RRAD and LATS2 expression at transcriptional level. This evidence concerns the gene DUXAP10 and non-small cell lung carcinoma.